Cancer

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Ronald Bailey | 8.19.2026 3:40 PM

Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google

Media Contact & Reprint Requests

(Guteksk7/Dreamstime.com/National Institutes of Health)

Pharmaceutical companies Moderna and Merck announced today the highly promising results of their anti-cancer mRNA vaccine Phase 3 clinical trial targeting later-stage melanoma skin cancers.

Researchers sequenced the DNA from each patient's tumors to create personalized vaccines that, when injected, rev up the immune system to........

© Reason.com